Song Bingbing, Chen Wenling, Marvizón Juan Carlos G
Center for Neurovisceral Sciences and Women's Health and CURE: Digestive Diseases Research Center, Division of Digestive Diseases, Department of Medicine, David Geffen School of Medicine at UCLA, Los Angeles, CA 90095, USA.
Brain Res. 2007 Jul 16;1158:57-62. doi: 10.1016/j.brainres.2007.05.006. Epub 2007 May 8.
Neurotransmitter receptors that inhibit the release of opioid peptides in the spinal cord may play an important role in modulating pain. Serotonin is an important neurotransmitter in bulbospinal descending pathways, and 5-HT(1) receptors have been shown to inhibit synaptic transmission. Our goal was to determine whether 5-HT(1A) receptors inhibit opioid release in the spinal cord. Opioid release was evoked from rat spinal cord slices by electrically stimulating one dorsal horn, and measured in situ through the internalization of micro-opioid receptors in dorsal horn neurons. Stimulation with 1000 square pulses at 500 Hz produced internalization in 60% of the mu-opioid receptor neurons in the stimulated dorsal horn, but not in the contralateral one. The selective 5-HT(1A) receptor agonist 8-hydroxy-2-dipropylaminotetralin (8-OH-DPAT) inhibited the evoked mu-opioid receptor internalization by about 50%, with an approximate IC(50) of 50 nM. The effect of 8-OH-DPAT was attributed to inhibition of opioid release and not of the receptor internalization process, because 8-OH-DPAT did not inhibit the internalization induced by incubating the slices with a micro-opioid receptor agonist (endomorphin-2, 100 nM). The selective 5-HT(1A) receptor antagonist WAY100135 (10 microM) blocked the inhibition produced by 1 microM 8-OH-DPAT. These results show that 5-HT(1A) receptors inhibit opioid release in the spinal dorsal horn, probably from a subpopulation of enkephalin-containing presynaptic terminals. Therefore, 5-HT(1A) receptors likely decrease the analgesia produced by endogenously released opioids.
抑制脊髓中阿片肽释放的神经递质受体可能在调节疼痛中发挥重要作用。血清素是延髓脊髓下行通路中的一种重要神经递质,并且5-羟色胺(5-HT)1型受体已被证明可抑制突触传递。我们的目标是确定5-HT1A型受体是否抑制脊髓中的阿片肽释放。通过电刺激一个背角从大鼠脊髓切片中诱发阿片肽释放,并通过背角神经元中微阿片受体的内化进行原位测量。以500Hz施加1000个方波脉冲刺激可使受刺激背角中60%的μ阿片受体神经元发生内化,但对侧背角则不会。选择性5-HT1A型受体激动剂8-羟基-2-二丙基氨基四氢萘(8-OH-DPAT)可将诱发的μ阿片受体内化抑制约50%,其半数抑制浓度(IC50)约为50nM。8-OH-DPAT的作用归因于对阿片肽释放的抑制,而非受体内化过程,因为8-OH-DPAT不会抑制用微阿片受体激动剂(内吗啡肽-
2,100nM)孵育切片所诱导的内化。选择性5-HT1A型受体拮抗剂WAY100135(10μM)可阻断1μM 8-OH-DPAT所产生的抑制作用。这些结果表明,5-HT1A型受体抑制脊髓背角中的阿片肽释放,可能是从含脑啡肽的突触前终末亚群释放。因此,5-HT1A型受体可能会降低内源性释放的阿片肽所产生的镇痛作用。